Impact Factor 2022: 1.8

Current issue – 04/2024

Identification of impactful imaging biomarker: Clinical applications for breast and prostate carcinoma

Bäuerle T, Dietzel M, Pinker K, et al.

Imaging biomarkers are quantitative parameters from imaging modalities, which are collected noninvasively, allow conclusions about physiological and pathophysiological processes, and may consist of single (monoparametric) or multiple parameters (bi- or multiparametric). This review aims to present the state of the art for the quantification of multimodal and multiparametric imaging biomarkers.





Imaging of Amyloid-Related Imaging Abnormalities (ARIA)

Urbach H, Linn J, Hattingen E, et al.

Patients with Alzheimer's disease (AD) can now be treated with monoclonal antibodies aiming at clearing amyloid plaques from the brain parenchyma. Weeks after initiation of this drug therapy, patients may develop so-called amyloidrelated imaging abnormalities (ARIA) on MRI. ARIA comprise vasogenic edema and leptomeningeal effusions (ARIA-E) as well as microbleeds and superficial hemosiderosis (ARIA-H).




Liver metastases of neuroendocrine tumors: Conventional transarterial chemoembolization and thermal ablation

Vogel TJ, Gruber-Rouh T, Naguib NNN, et al.

Purpose To identify prognostic factors for patients with neuroendocrine liver metastases (NELM) undergoing conventional transarterial chemoembolization (c-TACE), microwave ablation (MWA), or laser interstitial thermotherapy (LITT) and to determine the most effective therapy regarding volume reduction of NELM and survival.